Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis
暂无分享,去创建一个
M. Olaitan | Oluwatosin Qawiyy Orababa | U. Essiet | O. Ishola | O. Ogunrinde | O. Q. Orababa | M. Arowolo | O. Lagoke | E. Olumodeji | O. Orababa | J. D. Soriwei | B. V. Osibeluwo | O. H. Batholomew | O. M. Ezeani | A. O. Onishile | Margaret Toluwalayo Arowolo | Bisola Victoria Osibeluwo | Olajumoke Hanah Batholomew | O. Ogunrinde | Oluwaseyi Aminat Lagoke | Jeffrey Difiye Soriwei | Olanrewaju David Ishola | Onyinye Maryann Ezeani | Aminat Oyeronke Onishile | Elizabeth Olumodeji
[1] Alan D. Lopez,et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis , 2022, The Lancet.
[2] K. Hardie,et al. JMM Profile: Carbapenems: a broad-spectrum antibiotic , 2021, Journal of medical microbiology.
[3] A. Zerbo,et al. Water sanitation and hygiene in Sub-Saharan Africa: Coverage, risks of diarrheal diseases, and urbanization , 2021 .
[4] Yan Liu,et al. Retrospective Data Insight into the Global Distribution of Carbapenemase-Producing Pseudomonas aeruginosa , 2021, Antibiotics.
[5] Dan Yang,et al. Rapid Broad Spectrum Detection of Carbapenemases with a Dual Fluorogenic-Colorimetric Probe. , 2021, Journal of the American Chemical Society.
[6] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.
[7] S. Songca,et al. Prevalence and molecular analysis of multidrug-resistant Acinetobacter baumannii in the extra-hospital environment in Mthatha, South Africa , 2019, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[8] A. Whiteside,et al. New and Re-Emerging Infectious Diseases in Sub-Saharan Africa , 2017, Africa's Population: In Search of a Demographic Dividend.
[9] J. O'Neill,et al. Tackling drug-resistant infections globally: final report and recommendations , 2016 .
[10] Y. Carmeli,et al. The negative impact of antibiotic resistance. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[11] G. Meletis,et al. Carbapenem resistance: overview of the problem and future perspectives , 2016, Therapeutic advances in infectious disease.
[12] A. Pantosti,et al. Antimicrobial resistance: a global multifaceted phenomenon , 2015, Pathogens and global health.
[13] S. Amyes,et al. OXA β-Lactamases , 2014, Clinical Microbiology Reviews.
[14] G. B. Golding,et al. Antibiotic resistance is ancient , 2011, Nature.
[15] Damià Barceló,et al. Multi-residue analytical methods using LC-tandem MS for the determination of pharmaceuticals in environmental and wastewater samples: a review , 2006, Analytical and bioanalytical chemistry.
[16] L. Mandell,et al. Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects. , 1998, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.